Aldehyde dehydrogenase 2 Glu504Lys variant predicts a worse prognosis of acute coronary syndrome patients

Aldehyde dehydrogenase 2 ( ALDH 2) Glu504Lys variant was an independent risk factor for acute coronary syndrome ( ACS ). However, there are lacking researches about the relationship between the variant and prognosis of ACS . In the prospective study, 377 ACS patients were grouped into the wild‐type (*1/*1) and the mutation (*2/*2 + *1/*2) groups according to genotype detection. Compared with the wild‐type group, incidences of major adverse...